Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Caliber Imaging & Diagnostics develops and markets advanced, non-invasive imaging systems for cellular-level examination of skin and tissue, notably enabling 'optical biopsy' for the detection and diagnosis of skin cancers and other dermatologic disorders at the bedside. Their devices are used in major academic hospitals worldwide and have demonstrated clinical accuracy comparable to traditional histology in experienced hands, potentially reducing unnecessary biopsies. The company offers an integrated platform combining imaging hardware and telepathology services for real-time collaboration among specialists[4][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Caliber Imaging & Diagnostics.